Delivery Order SPE2DB24D6044-SPE2DB25FLJLF
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,119.11 to AmerisourceBergen Drug Corp for the supply of Potassium Phosphate 15 mmol/5 ml in 5 ml vials. This firm fixed-price, competitively awarded delivery order was issued on August 28, 2025, with an ultimate completion date of August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents no set-aside designation and falls under standard...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for potassium phosphate 15 mmol/5 ml vials valued at $4,328.93 on August 12, 2025. This firm fixed-price delivery order, which is not set-aside, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with completion scheduled for August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the...
- This is a $3,991.46 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 15 milliliter vials of Potassium Phosphate, a medication used for electrolyte imbalances. The contract has an ultimate completion date of May 13, 2025. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $2,528.41 firm fixed price delivery order is for the supply of 4564094917 - Potassium Phosphate 45 MMOL/15 ML 15ML, with a performance period through March 28, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with...
- This is a delivery order award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,957.32 firm fixed-price contract is for the delivery of 5 milliliter vials of potassium phosphate, a medication. The contract has an ultimate completion date of June 24, 2025 and was awarded on June 23, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- The Defense Logistics Agency awarded a $412 delivery order to Amerisourcebergen Drug Corporation for potassium phosphate 45mmol/15ml single-dose vials. The firm fixed price order is for product delivery to a facility in Conshohocken, Pennsylvania between July 5-6, 2023. Amerisourcebergen will supply the pharmaceutical items to the DLA under the contract. No additional details were provided regarding the original solicitation, subcontractors involved, or whether the award includes any set aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The contract, valued at $3,965.52, is for the delivery of Potassium Phosphate 45 mmol/15 mL medication vials. The contract is a Firm Fixed Price Delivery Order with a completion date of November 7, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Potassium Chloride Extended Release 20 MEQ tablets in quantities of 500 units, with a contract ceiling value of approximately $8,000. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on August 21, 2025, and will be performed at AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,586.87 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of potassium chloride extended-release tablets. The $3,905.52 firm-fixed-price delivery order has a completion date of November 14, 2022 and was awarded on November 10, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB24D6044Indefinite Delivery Contract
- SPE2DB24D6044-SPE2DB25FLJLFDelivery Order
The Defense Logistics Agency awarded a $1,842.03 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Potassium Phosphate 45 mmol/15 ml pharmaceutical product. This firm fixed price, non-set-aside contract is scheduled for completion by September 4, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant indefinite delivery contract with DLA Troop Support Medical (SPE2DX) valued at $999,999,999.00 through December 2026, which serves as the overarching vehicle enabling the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This delivery order represents a routine procurement under AmerisourceBergen's existing prime indefinite delivery contract with the Defense Logistics Agency. The company maintains an extensive portfolio of federal medical supply contracts with DLA and continues to serve critical defense healthcare needs through its capability to supply brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The non-set-aside competitive award demonstrates AmerisourceBergen's continued qualification to meet federal procurement requirements for pharmaceutical support to military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/3/25 |